Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionRhumbline Advisers
Latest Disclosed Ownership190,698 shares
Latest Disclosed Value $ 7,686,995
Rhumbline Advisers reports 2.15% increase in ownership of HTD / Corcept Therapeutics Incorporated

On May 12, 2026 - Rhumbline Advisers filed a 13F-HR form disclosing ownership of 190,698 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $6,577,174 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 186,688 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 2.15% during the quarter. The current value of the position is $12,059,742 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 190,698 4,010 2.15 7,687 18.32 0.0066
2026-02-13 2025-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 186,688 -1,530 -0.81 6,497 -58.47 0.0053
2025-11-06 2025-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 188,218 1,747 0.94 15,643 14.29 0.0126
2025-08-12 2025-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 186,471 -14,930 -7.41 13,687 -40.50 0.0117
2025-05-29 2025-03-31 13F/A-1 CORCEPT THERAPEUTICS INC COM COM 218352102 201,401 565 0.28 23,004 127.30 0.0215
2025-04-08 2025-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 201,401 565 23,004 0.0215
2025-05-29 2024-12-31 13F/A-1 CORCEPT THERAPEUTICS INC COM COM 218352102 200,836 -1,996 -0.98 10,120 7.81 0.0091
2025-01-30 2024-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 200,836 -1,996 10,120 0.0091
2024-11-12 2024-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 202,832 44 0.02 9,387 42.49 0.0085
2024-08-01 2024-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 202,788 -3,956 -1.91 6,589 26.52 0.0062
2024-05-09 2024-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 206,744 -5,549 -2.61 5,208 -24.48 0.0050
2024-02-08 2023-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 212,293 7,035 3.43 6,895 23.30 0.0072
2023-11-09 2023-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 205,258 454 0.22 5,592 22.74 0.0065
2023-08-08 2023-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 204,804 -5,980 -2.84 4,557 113,800.00 0.0051
2023-05-11 2023-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 210,784 12,976 6.56 5 -99.90 0.0056
2023-02-14 2022-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 197,808 1,054 0.54 4,017 -20.38 0.0054
2022-11-10 2022-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 196,754 9,881 5.29 5,045 13.52 0.0075
2022-08-11 2022-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 186,873 5,417 2.99 4,444 8.76 0.0065
2022-05-12 2022-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 181,456 2,895 1.62 4,086 15.55 0.0053
2022-02-10 2021-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 178,561 -1,064 -0.59 3,536 0.03 0.0043
2021-11-12 2021-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 179,625 -39,987 -18.21 3,535 -26.83 0.0048
2021-08-05 2021-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 219,612 -3,832 -1.71 4,831 -9.12 0.0063
2021-05-06 2021-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 223,444 5,534 2.54 5,316 -6.75 0.0072
2021-02-10 2020-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 217,910 63 0.03 5,701 50.34 0.0079
2020-11-12 2020-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 217,847 -22,385 -9.32 3,792 -6.16 0.0059
2020-08-13 2020-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 240,232 -13,891 -5.47 4,041 33.72 0.0067
2020-05-06 2020-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 254,123 2,100 0.83 3,022 -0.89 0.0063
2020-02-05 2019-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 252,023 19,240 8.27 3,049 -7.33 0.0051
2019-10-23 2019-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 232,783 179 0.08 3,290 26.83 0.0060
2019-08-14 2019-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 232,604 4,416 1.94 2,594 -3.17 0.0049
2019-05-01 2019-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 228,188 -2,778 -1.20 2,679 -13.19 0.0052
2019-01-31 2018-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 230,966 46,944 25.51 3,086 19.61 0.0067
2018-11-07 2018-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 184,022 775 0.42 2,580 -10.45 0.0050
2018-08-06 2018-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 183,247 11,790 6.88 2,881 2.16 0.0058
2018-05-02 2018-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 171,457 3,400 2.02 2,820 -7.08 0.0059
2018-02-09 2017-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 168,057 78,700 88.07 3,035 75.94 0.0062
2017-11-06 2017-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 89,357 1,685 1.92 1,725 66.67 0.0038
2017-08-02 2017-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 87,672 15,494 21.47 1,035 30.85 0.0024
2017-05-02 2017-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 72,178 2,492 3.58 791 56.32 0.0018
2017-01-27 2016-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 69,686 9,684 16.14 506 29.74 0.0013
2016-11-08 2016-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 60,002 3,139 5.52 390 25.81 0.0011
2016-08-11 2016-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 56,863 8,272 17.02 310 36.56 0.0009
2016-05-02 2016-03-31 13F CORCEPT THERAPEUTICS INC COMMO COM 218352102 48,591 -40 -0.08 227 -6.20 0.0007
2016-02-03 2015-12-31 13F CORCEPT THERAPEUTICS INC COMMO COM 218352102 48,631 4,855 11.09 242 46.67 0.0008
2015-11-04 2015-09-30 13F CORCEPT THERAPEUTICS INC COMMO COM 218352102 43,776 1,951 4.66 165 -34.26 0.0006
2015-08-04 2015-06-30 13F CORCEPT THERAPEUTICS INC COMMO COM 218352102 41,825 -1,650 -3.80 251 3.29 0.0008
2015-05-12 2015-03-31 13F CORCEPT THERAPEUTICS INC COMMO COM 218352102 43,475 10,100 30.26 243 143.00 0.0007
2015-02-06 2014-12-31 13F CORCEPT THERAPEUTICS INC COMMO COM 218352102 33,375 -8,510 -20.32 100 -10.71 0.0003
2014-11-12 2014-09-30 13F CORCEPT THERAPEUTICS INC COMMO COM 218352102 41,885 0 0.00 112 -4.27 0.0003
2014-08-06 2014-06-30 13F CORCEPT THERAPEUTICS INC COMMO COM 218352102 41,885 -1,620 -3.72 117 -38.42 0.0003
2014-05-06 2014-03-31 13F CORCEPT THERAPEUTICS INC COMMO COM 218352102 43,505 -2,600 -5.64 190 28.38 0.0006
2014-02-03 2013-12-31 13F CORCEPT THERAPEUTICS INC COMMO COM 218352102 46,105 -200 -0.43 148 100.00 0.0004
2013-11-05 2013-09-30 13F CORCEPT THERAPEUTICS INC COMMO COM 218352102 46,305 -491 -1.05 74 -8.64 0.0002
2013-08-07 2013-06-30 13F CORCEPT THERAPEUTICS INC COMMO COM 218352102 46,796 46,796 81 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.